Peter M Shaw
Affiliation: Merck Research Laboratories
- Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomicsPeter M Shaw
Merck and Co, Inc, Pharmacogenetics and Molecular Profiling, West Point, PA 19486, USA
Pharmacogenomics 11:1629-35. 2010..Furthermore, the complexities of conducting pharmacogenetic research in global drug-development programs was acknowledged as was the need for rigorous research designs and methodologies despite these challenges...
- EMT is the dominant program in human colon cancerAndre Loboda
Merck, Sharp and Dohme, West Point, PA 19486, USA
BMC Med Genomics 4:9. 2011..Colon cancer has been classically described by clinicopathologic features that permit the prediction of outcome only after surgical resection and staging...